Akiko Tonosaki1, Miharu Ishikawa2. 1. National College of Nursing, Japan. Electronic address: tonosakia@adm.ncn.ac.jp. 2. National Cancer Center Hospital East, Japan.
Abstract
PURPOSE: The aim was to evaluate the physical activity intensity (PAI) of patients receiving adjuvant chemotherapy and investigate the relationship between health status perception and PAI in Japan. METHODS: Consenting participants of this prospective, descriptive, repeated measures design were 28 women aged 20-64 with stage I-IIIA initial breast cancer whose regimen included anthracycline. Participants wore a triaxial accelerometer and their PAI was measured for a 14-day period at the beginning of chemotherapy. The SF-36 Survey and Cancer Fatigue Scale were administered. The accelerometer was used to calculate the number of steps, physical activity level (PAL) and total minutes of PAI levels of under 1.5 Mets, 1.5-2.9 Mets, and more than 3.0 Mets during the first half (FH; days 2-7) and second half (SH; days 8-14) of the study. Data were analyzed using Pearson's correlation coefficient and multiple regression analysis. RESULTS: During FH, the mean number of steps was 3841.1 steps/day and mean PAL was 1.43; during SH, the mean number of steps was 4058.4 steps/day, mean PAL was 1.43; participants spent over 70% of the day working quietly in a sitting position. PAL during SH was significantly associated with mean time spent during activities of 1.5-2.9 Mets (β = 0.880, p < 0.0001) and 3.0 Mets (β = 0.268, p < 0.0001). CONCLUSION: Patients receiving adjuvant chemotherapy had extremely low physical activity. They should be provided useful information of appropriate physical movement and be supported in resolving physical and psychological distress.
PURPOSE: The aim was to evaluate the physical activity intensity (PAI) of patients receiving adjuvant chemotherapy and investigate the relationship between health status perception and PAI in Japan. METHODS: Consenting participants of this prospective, descriptive, repeated measures design were 28 women aged 20-64 with stage I-IIIA initial breast cancer whose regimen included anthracycline. Participants wore a triaxial accelerometer and their PAI was measured for a 14-day period at the beginning of chemotherapy. The SF-36 Survey and Cancer Fatigue Scale were administered. The accelerometer was used to calculate the number of steps, physical activity level (PAL) and total minutes of PAI levels of under 1.5 Mets, 1.5-2.9 Mets, and more than 3.0 Mets during the first half (FH; days 2-7) and second half (SH; days 8-14) of the study. Data were analyzed using Pearson's correlation coefficient and multiple regression analysis. RESULTS: During FH, the mean number of steps was 3841.1 steps/day and mean PAL was 1.43; during SH, the mean number of steps was 4058.4 steps/day, mean PAL was 1.43; participants spent over 70% of the day working quietly in a sitting position. PAL during SH was significantly associated with mean time spent during activities of 1.5-2.9 Mets (β = 0.880, p < 0.0001) and 3.0 Mets (β = 0.268, p < 0.0001). CONCLUSION:Patients receiving adjuvant chemotherapy had extremely low physical activity. They should be provided useful information of appropriate physical movement and be supported in resolving physical and psychological distress.
Authors: Sandahl H Nelson; Lauren S Weiner; Loki Natarajan; Barbara A Parker; Ruth E Patterson; Sheri J Hartman Journal: Transl Behav Med Date: 2020-10-08 Impact factor: 3.046
Authors: Madelyn Whitaker; Whitney A Welch; Jason Fanning; Cesar A Santa-Maria; Lisa A Auster-Gussman; Payton Solk; Seema A Khan; Swati A Kulkarni; William Gradishar; Juned Siddique; Siobhan M Phillips Journal: Support Care Cancer Date: 2022-04-30 Impact factor: 3.603
Authors: Marloes G M Derks; Nienke A de Glas; Esther Bastiaannet; Anton J M de Craen; Johanneke E A Portielje; Cornelis J H van de Velde; Floor E van Leeuwen; Gerrit-Jan Liefers Journal: Oncologist Date: 2016-07-01
Authors: H Helbrich; M Braun; C Hanusch; G Mueller; H Falk; R Flondor; N Harbeck; K Hermelink; R Wuerstlein; S Keim; F Neufeld; S Steins-Loeber; K Haertl Journal: Breast Cancer Res Treat Date: 2021-03-31 Impact factor: 4.872
Authors: Tom Møller; Christian Lillelund; Christina Andersen; Kira Bloomquist; Karl Bang Christensen; Bent Ejlertsen; Lone Nørgaard; Liza Wiedenbein; Peter Oturai; Ulla Breitenstein; Lis Adamsen Journal: BMJ Open Sport Exerc Med Date: 2015-10-23
Authors: Lee Smith; Jung Ae Lee; Junbae Mun; Ratna Pakpahan; Kellie R Imm; Sonya Izadi; Adam S Kibel; Graham A Colditz; Robert L Grubb; Kathleen Y Wolin; Siobhan Sutcliffe; Lin Yang Journal: Cancer Date: 2018-12-05 Impact factor: 6.860
Authors: Siobhan M Phillips; Whitney A Welch; Jason Fanning; Cesar A Santa-Maria; Kara L Gavin; Lisa A Auster-Gussman; Payton Solk; Marilyn Lu; Erin Cullather; Seema A Khan; Swati A Kulkarni; William Gradishar; Juned Siddique Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-09-29 Impact factor: 4.254